Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Amortization of Deferred Charges: 2019-2024

Historic Amortization of Deferred Charges for Wave Life Sciences (WVE) over the last 6 years, with Dec 2024 value amounting to $4.8 million.

  • Wave Life Sciences' Amortization of Deferred Charges rose 13.55% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 13.51%. This contributed to the annual value of $4.8 million for FY2024, which is 13.34% up from last year.
  • Latest data reveals that Wave Life Sciences reported Amortization of Deferred Charges of $4.8 million as of FY2024, which was up 13.34% from $4.2 million recorded in FY2023.
  • Over the past 5 years, Wave Life Sciences' Amortization of Deferred Charges peaked at $4.8 million during FY2024, and registered a low of $1.9 million during FY2020.
  • For the 3-year period, Wave Life Sciences' Amortization of Deferred Charges averaged around $4.2 million, with its median value being $4.2 million (2023).
  • Data for Wave Life Sciences' Amortization of Deferred Charges shows a peak YoY spiked of 50.51% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Wave Life Sciences' Amortization of Deferred Charges stood at $1.9 million in 2020, then rose by 25.84% to $2.4 million in 2021, then soared by 50.51% to $3.5 million in 2022, then increased by 18.81% to $4.2 million in 2023, then increased by 13.34% to $4.8 million in 2024.